
Contents
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Streptococcal infections Streptococcal infections
-
Group A: Streptococcus pyogenes Group A: Streptococcus pyogenes
-
Management Management
-
-
Group B β-haemolytic streptococci (GBS): Streptococcus agalactiae Group B β-haemolytic streptococci (GBS): Streptococcus agalactiae
-
-
Staphylococcus aureus Staphylococcus aureus
-
Management Management
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
31 Streptococcal and staphylococcal infections
-
Published:September 2010
Cite
Streptococcal infections
Group A: Streptococcus pyogenes
Unusual cause of acute purulent vaginitis, generally related to obstetric or other trauma. May lead to necrotizing fasciitis.
Recognized cause of acute vaginitis in pre-pubertal girls.
May rarely cause balanitis (e.g. pyoderma following fellatio).
Management
Simple infections pending antibiotic sensitivities:
phenoxymethylpenicillin (penicillin V) 500mg 4 times daily for 7–10 days.
Group B β-haemolytic streptococci (GBS): Streptococcus agalactiae
Found in 12–37% of ♀ attending GUM clinics. Usually not pathogenic (except in pregnancy) but associated with bacterial vaginosis.
Pregnancy
Carriage rate is 6–28%. Intra-amniotic infection and postpartum endometritis if heavily colonized. ~35% of babies of carriers become colonized, with ~1% developing invasive neonatal infection with an incidence of 1 in 2000 births. GBS is the most frequent cause of any severe infection in infants aged <7 days. Septicaemia, meningitis, pulmonary infection, and shock may follow in up to 50% of infected infants with a mortality of 6% if full term and 18% if preterm.
Risk factors for neonatal infection are:
labour <37 weeks
prolonged rupture of membranes (PROM) >18 hours
intrapartum pyrexia
GBS bacteriuria in current pregnancy
previous infant with GBS.
In the UK, women identified with these risk factors are offered intrapartum antibiotics to prevent neonatal infection (Box 31.1). Recommended regimen is iv benzyl penicillin 3g (5mu) at onset of labour, then 1.5g (2.5mu) 4 hourly until delivery. Clindamycin 900mg should be given iv 8 hourly to those allergic to penicillin.
Intrapartum prophylaxis should be offered to those ♀ with risk factors.
Intrapartum prophylaxis is not indicated if GBS carriage was detected in a previous pregnancy.
Routine screening for antenatal GBS carriage is not recommended.
Intrapartum antibiotic prophylaxis should be considered if GBS is incidentally detected in a vaginal/rectal swab. However, treatment before labour is not recommended (recolonization likely).
Practice varies worldwide, e.g. US guidelines recommend that all women are screened (vaginal/rectal swabs) at 35–37 weeks for GBS and prophylactic intrapartum antibiotics offered to those testing positive (or not tested). This results in 30–50% of women receiving IV prophylactic antibiotics during labour. Risk-factor-based approach is estimated to ↓ early onset of GBS disease of the neonate by 50–69%, while prophylaxis based on routine swabs may ↓ it by 86%.
Men
Urethral colonization in 38–46% of ♂ attending GUM clinics. GBS may cause balanitis, usually mild but rarely progressing to cellulitis. GBS also occasionally implicated in balanitis.
Staphylococcus aureus
Vaginal carriage rate is ~10%.
Folliculitis.
Local genital or peri-genital infection, including abscesses, especially in traumatized skin (e.g. excoriation with scabies). Cases of community-associated meticillin-resistant Staph. aureus (MRSA) infections transmitted heterosexually have been reported, presenting as abscesses or folliculitis involving the pubic, vaginal, or perineal region. These have been documented without any evidence of nasal colonization in 75% of people with active genital/peri-genital infection or colonization.
Toxic shock syndrome. Caused by an exotoxin produced by phage group 1 Staph. aureus colonizing the vagina. It usually arises midway through menstruation and is associated with super-absorbent tampons (now discontinued), infrequent tampon change, or rarely the use of the contraceptive diaphragm. Typically sudden onset of sore throat, pyrexia, headache, myalgia, vomiting, diarrhoea, abdominal pain, and vaginal irritation, followed by a generalized rash, inflammation of oral and vaginal mucosae, vasoconstriction, hypotension, and shock. Skin desquamation and necrosis are common sequelae. Tampons should be changed regularly and diaphragms should not be left in situ for longer than the contraceptive needs dictate.
Management
Simple infections pending antibiotic sensitivities: flucloxacillin 250–500mg 4 times daily for 5 days.
Toxic shock syndrome: supportive treatment (for shock), removal of retained tampon or diaphragm, and treatment with high-dose anti-biotics.
Month: | Total Views: |
---|---|
October 2022 | 3 |
December 2022 | 3 |
January 2023 | 4 |
February 2023 | 4 |
March 2023 | 4 |
April 2023 | 1 |
May 2023 | 2 |
June 2023 | 2 |
July 2023 | 2 |
August 2023 | 2 |
September 2023 | 3 |
October 2023 | 5 |
November 2023 | 2 |
December 2023 | 5 |
January 2024 | 1 |
February 2024 | 1 |
March 2024 | 3 |
April 2024 | 1 |
May 2024 | 2 |
June 2024 | 3 |
July 2024 | 1 |
August 2024 | 1 |